NCT04197310 2025-01-31Cabozantinib and Nivolumab for Carcinoid TumorsDana-Farber Cancer InstitutePhase 2 Completed19 enrolled 10 charts
NCT01466036 2024-03-05Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid TumorsDana-Farber Cancer InstitutePhase 2 Completed61 enrolled 9 charts